Skip to content

Clinical trials

Phase 3 Hyperlipidemias trials in South Africa

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperlipidemias Phase: Phase 3 Country / region: South Africa Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20054
20061
20071
20081
20138
20171
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated3
Active, not recruiting2
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen7
Novartis Pharmaceuticals4
Pfizer4
Takeda4
Kastle Therapeutics, LLC2
Bayer1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
Solvay Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperlipidemias24
Hypercholesterolemia15
Dyslipidemias8
Hyperlipoproteinemia Type II6
Cardiovascular Diseases5
Homozygous Familial Hypercholesterolemia3
Myocardial Infarction3
Stroke3
Aortic Valve Stenosis2
Congenital Abnormalities2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.